| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Obstacles to residents' conducting research and predictors of publication.
|
Acad Med
|
2001
|
2.25
|
|
2
|
Review article: possible beneficial effects of coffee on liver disease and function.
|
Aliment Pharmacol Ther
|
2007
|
1.61
|
|
3
|
Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3.
|
J Viral Hepat
|
2008
|
1.45
|
|
4
|
Analysis of causes of death in liver transplant recipients who survived more than 3 years.
|
Liver Transpl
|
2001
|
1.40
|
|
5
|
Primary biliary cirrhosis and inflammatory bowel disease.
|
Am J Gastroenterol
|
1993
|
1.39
|
|
6
|
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy.
|
Gut
|
2006
|
1.22
|
|
7
|
Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis.
|
Am J Transplant
|
2006
|
1.20
|
|
8
|
Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice.
|
Aliment Pharmacol Ther
|
2006
|
1.07
|
|
9
|
An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.
|
J Viral Hepat
|
2008
|
1.02
|
|
10
|
Obscure gastrointestinal bleeding from an ampullary tumour in a patient with a remote history of renal cell carcinoma: a diagnostic conundrum.
|
Can J Gastroenterol
|
1998
|
1.01
|
|
11
|
Massive bleeding from multiple gastric ulcerations in a patient with lymphocytic gastritis and celiac sprue.
|
J Clin Gastroenterol
|
1997
|
0.98
|
|
12
|
Chinese herbal medicine, fulminant hepatitis, and liver transplantation.
|
Am J Gastroenterol
|
1996
|
0.95
|
|
13
|
Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance.
|
J Hepatol
|
2000
|
0.94
|
|
14
|
Diminutive but dangerous: a case of a polypoid rectal arteriovenous malformation.
|
Endoscopy
|
2002
|
0.94
|
|
15
|
Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
|
Transpl Infect Dis
|
2012
|
0.90
|
|
16
|
Coexisting carcinoid tumors in familial adenomatous polyposis-associated upper intestinal adenomas.
|
Am J Gastroenterol
|
1999
|
0.88
|
|
17
|
Liver test abnormalities in multiple sclerosis: findings from placebo-treated patients.
|
Neurology
|
2006
|
0.87
|
|
18
|
Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine.
|
Transplantation
|
1997
|
0.85
|
|
19
|
Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysis.
|
Ann Oncol
|
1999
|
0.84
|
|
20
|
Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin.
|
Aliment Pharmacol Ther
|
2013
|
0.84
|
|
21
|
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin.
|
Aliment Pharmacol Ther
|
2008
|
0.83
|
|
22
|
Liver biochemistry abnormalities in a quaternary care lipid clinic database.
|
Ann Hepatol
|
2008
|
0.82
|
|
23
|
Primary protein-losing enteropathy in anti-double-stranded DNA disease: the initial and sole clinical manifestation of occult systemic lupus erythematosus?
|
J Clin Gastroenterol
|
2001
|
0.82
|
|
24
|
Colonic malakoplakia in a liver transplant recipient.
|
Can J Gastroenterol
|
2007
|
0.81
|
|
25
|
Failure of ketoprofen and interferon combination therapy to improve interferon-resistant chronic hepatitis C.
|
Can J Gastroenterol
|
1997
|
0.80
|
|
26
|
Impaired exercise performance after successful liver transplantation.
|
Transplantation
|
2001
|
0.80
|
|
27
|
Correlation between physiological assessment and outcome after liver transplantation.
|
Am J Surg
|
2000
|
0.79
|
|
28
|
Assessment of immunologic status of liver transplant recipients by peripheral blood mononuclear cells in response to stimulation by donor alloantigen.
|
Ann Surg
|
1999
|
0.78
|
|
29
|
Hyperammonemia after heart-lung transplantation.
|
Gastroenterology
|
1997
|
0.76
|
|
30
|
Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production.
|
Immunol Lett
|
1998
|
0.76
|
|
31
|
Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada.
|
Can J Gastroenterol
|
2008
|
0.76
|
|
32
|
A study of the pharmacokinetic profile of low-dose hepatitis B immune globulin in long-term liver transplant recipients for chronic hepatitis B infection.
|
Am J Transplant
|
2001
|
0.75
|
|
33
|
Orthotopic liver transplantation in a patient with carbamyl phosphate synthetase deficiency and cystic fibrosis.
|
Paediatr Child Health
|
2003
|
0.75
|
|
34
|
Barriers to transplantation in adults with inborn errors of metabolism.
|
JIMD Rep
|
2012
|
0.75
|
|
35
|
Hepatitis C and B-cell non-Hodgkin's lymphoma: a geographically variable association?
|
Am J Med
|
2000
|
0.75
|
|
36
|
Crohn's disease, HIV, and AIDS.
|
Am J Gastroenterol
|
1995
|
0.75
|
|
37
|
All that bleeds is not infliximab-refractory ulcerative colitis.
|
Can J Gastroenterol
|
2009
|
0.75
|
|
38
|
Lovastatin and cholestasis.
|
CMAJ
|
1993
|
0.75
|
|
39
|
Tomorrow's challenge in liver transplantation: diminishing the imbalance between donor organ availability and need.
|
Gut
|
1998
|
0.75
|
|
40
|
The use of interferon-alpha 2B in the treatment of chronic viral hepatitis in patients with preexisting idiopathic thrombocytopenic purpura.
|
Am J Gastroenterol
|
1995
|
0.75
|
|
41
|
Lung dysfunction and chronic liver disease.
|
Ann Intern Med
|
1996
|
0.75
|
|
42
|
Carcinoid tumors of the small intestine are uncommon, indolent, slow growing, slow metastasizing, neuroendocrine lesions.
|
World J Surg
|
1994
|
0.75
|
|
43
|
Primary induction with mycophenolate mofetil and corticosteroids in a liver transplant recipient with hepatorenal syndrome.
|
Ann Pharmacother
|
1998
|
0.75
|
|
44
|
Assessing virologic efficacy of combination lamivudine and low-dose hepatitis B immune globulin posttransplantation with the ultrasensitive digene hybrid capture II assay.
|
Liver Transpl
|
2000
|
0.75
|
|
45
|
Post-surgical shunt hepatopulmonary syndrome in a case of non-cirrhotic portal hypertension: lack of efficacy of shunt reversal.
|
Eur J Gastroenterol Hepatol
|
1999
|
0.75
|
|
46
|
Peritoneal dialysis after orthotopic liver transplant surgery.
|
Perit Dial Int
|
2006
|
0.75
|
|
47
|
Liver enzymes as surrogate markers of hepatitis C histopathology--avoiding the liver biopsy needle?
|
Can J Gastroenterol
|
2001
|
0.75
|
|
48
|
De Novo Crohn's disease in AIDS: Crohn's disease or Crohn's "syndrome"?
|
J Clin Gastroenterol
|
1998
|
0.75
|
|
49
|
A case of recurrent pyogenic cholangitis.
|
Dig Liver Dis
|
2007
|
0.75
|
|
50
|
Acute pseudohepatitis in a chronic substance abuser secondary to occult seat belt injury.
|
Can J Gastroenterol
|
1999
|
0.75
|
|
51
|
Diabetes mellitus after liver transplantation: another extrahepatic manifestation of hepatitis C.
|
Can J Gastroenterol
|
2001
|
0.75
|
|
52
|
Hepatic abscesses after liver transplantation secondary to traumatic intrahepatic bile duct injuries in a cadaveric allograft donor.
|
Transpl Int
|
2004
|
0.75
|
|
53
|
Issues in organ procurement: presumed consent, bioethical type II errors, and organ registries.
|
Ann R Coll Physicians Surg Can
|
1998
|
0.75
|
|
54
|
Recurrent hepatocellular carcinoma after liver transplantation mimicking post-transplantation lymphoproliferative disorder.
|
Australas Radiol
|
2005
|
0.75
|
|
55
|
Palliative high-dose octreotide in a case of severe AIDS-related diarrhea.
|
Ann Pharmacother
|
1994
|
0.75
|